These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2162412)

  • 1. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K; Okura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S; Ohyanagi H; Saitoh Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H; Sakawaki T
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T; Morimoto H; Saito M; Mori T
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].
    Sekine T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1028-30. PubMed ID: 2192104
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N; Satomura Y
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A; Hinoda Y; Imai K; Endo T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M; Fujisawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K; Mitsuhashi F; Ohkura H
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
    Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
    Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in the diagnosis of tumors of the liver and biliary tract].
    Marecek Z
    Vnitr Lek; 1997 Mar; 43(3):167-70. PubMed ID: 9221578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of CA 130 assay as a tumor marker].
    Ariyoshi Y; Kuwabara M
    Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early diagnostic system of minute hepatocellular carcinoma, and neoplasms of biliary tract and pancreas].
    Okuda K; Tsuchiya Y; Saisho H
    Nihon Rinsho; 1982; 40(1):146-50. PubMed ID: 6283199
    [No Abstract]   [Full Text] [Related]  

  • 15. A new monoclonal-antibody-defined tumor marker (KMO1) for pancreatic carcinoma.
    Ohyanagi H; Saitoh Y; Okumura S; Ishida T; Uesaka K; Ishida H; Yamamoto M; Uemura Y; Kano Y; Suyama T
    Mt Sinai J Med; 1987 Jun; 54(5):393-400. PubMed ID: 3498891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor markers for hepatoma and carcinoma of biliary tract].
    Higashino K
    Rinsho Byori; 1985 Aug; 33(8):861-71. PubMed ID: 2416966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serodiagnosis: tumor marker].
    Yoneshima M; Hattori N; Sawabu N
    Gan No Rinsho; 1988 Aug; 34(10):1209-15. PubMed ID: 2459425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)].
    Sakurabayashi I; Kawai T; Omizo R; Hattori N; Ishii M
    Rinsho Byori; 1988 Dec; 36(12):1407-12. PubMed ID: 2854864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.